Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000688257 | SCV000815862 | benign | Amyotrophic lateral sclerosis type 4; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2024-01-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002325367 | SCV002609094 | uncertain significance | Inborn genetic diseases | 2022-03-20 | criteria provided, single submitter | clinical testing | The p.I1114T variant (also known as c.3341T>C), located in coding exon 8 of the SETX gene, results from a T to C substitution at nucleotide position 3341. The isoleucine at codon 1114 is replaced by threonine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the supporting evidence, this variant is unlikely to be causative of juvenile amyotrophic lateral sclerosis 4 (ALS4); however, its contribution to the development of spinocerebellar ataxia with axonal neuropathy 2 (SCAN2) is uncertain. |